Company Filing History:
Years Active: 2025
Title: Celebrating the Innovations of Samuel T. Albright in Kinase Inhibition
Introduction
Samuel T. Albright, an accomplished inventor based in San Diego, California, has made significant contributions to the field of biomedical research. With a keen focus on kinase inhibitors, his work addresses crucial medical challenges associated with selective BTK kinase inhibition, paving the way for new therapeutic approaches.
Latest Patents
Albright holds a noteworthy patent for "Selective BTK irreversible inhibitors." This invention introduces a series of conformationally stable and selective, irreversible kinase inhibitors. The methods accompanying this patent assess the effect of atropisomerism on kinase selectivity, highlighting improved selectivity in contrast to rapidly interconverting parent compounds. The compounds developed in this patent are atropisomers designed for treating conditions that benefit from selective BTK kinase inhibition.
Career Highlights
Currently, Samuel T. Albright is affiliated with the San Diego State University Foundation, where he leverages his expertise in research and innovation. His dedication to scientific advancement has positioned him as a prominent figure in his field, contributing to transformative research that has substantial clinical implications.
Collaborations
Throughout his career, Albright has collaborated with notable individuals in the scientific community, including his coworker Jeffrey L. Gustafson. These partnerships amplify the impact of his research, enabling the blending of diverse expertise to enhance the effectiveness of his innovations.
Conclusion
Samuel T. Albright's innovative work in developing selective BTK irreversible inhibitors represents a significant advancement in pharmacology. His dedication to research at the San Diego State University Foundation exemplifies the vital role of inventors in shaping the future of medicine and improving patient outcomes. As the field of biomedical research continues to evolve, the contributions of inventors like Albright remain crucial in driving forward innovation and therapeutic solutions.